Dr. Reddy's Laboratories Ltd Q2FY21 consolidated PAT at Rs. 762.3 crore

DR.REDDY'S LABORATORIES LTD. has reported financial results for the period ended September 30, 2020.

Financial Results (Q2 FY20-21) - QoQ Comparison

The company has reported total income of Rs.4896.7 crores during the period ended September 30, 2020 as compared to Rs.4417.5 crores during the period ended June 30, 2020.

The company has posted net profit / (loss) of Rs.762.3 crores for the period ended September 30, 2020 as against net profit / (loss) of Rs.579.3 crores for the period ended June 30, 2020.

The company has reported EPS of Rs.45.83 for the period ended September 30, 2020 as compared to Rs.34.86 for the period ended June 30, 2020.

Financials	Q2 FY20-21	Q1 FY20-21	% Change
Total Income	₹ 4896.7 crs	₹ 4417.5 crs	10.85%
Net Profit	₹ 762.3 crs	₹ 579.3 crs	31.59%
EPS	₹ 45.83	₹ 34.86	31.47%

Financial Results (Q2 FY20-21) - YoY Comparison

The company has reported total income of Rs.4896.7 crores during the period ended September 30, 2020 as compared to Rs.4800.9 crores during the period ended September 30, 2019.

The company has posted net profit / (loss) of Rs.762.3 crores for the period ended September 30, 2020 as against net profit / (loss) of Rs.1092.5 crores for the period ended September 30, 2019.

The company has reported EPS of Rs.45.83 for the period ended September 30, 2020 as compared to Rs.65.82 for the period ended September 30, 2019.

Financials	Q2 FY20-21	Q2 FY19-20	% Change
Total Income	₹ 4896.7 crs	₹ 4800.9 crs	2%
Net Profit	₹ 762.3 crs	₹ 1092.5 crs	-30.22%
EPS	₹ 45.83	₹ 65.82	-30.37%

Financial Results (6 months ended FY 20-21) - YoY Comparison

The company has reported total income of Rs.9314.2 crores during the 6 months period ended September 30, 2020 as compared to Rs.8644.4 crores during the 6 months period ended September 30, 2019.

The company has posted net profit / (loss) of Rs.1341.6 crores for the 6 months period ended September 30, 2020 as against net profit / (loss) of Rs.1755.3 crores for the 6 months period ended September 30, 2019.

The company has reported EPS of Rs.80.69 for the 6 months period ended September 30, 2020 as compared to Rs.105.71 for the 6 months period ended September 30, 2019.

Financials	Half-Year Ended FY20-21	Half-Year Ended FY19-20	% Change
Total Income	₹ 9314.2 crs	₹ 8644.4 crs	7.75%
Net Profit	₹ 1341.6 crs	₹ 1755.3 crs	-23.57%
EPS	₹ 80.69	₹105.71	-23.67%

Commenting on the results, Co-chairman & MD, G V Prasad said "We are pleased to report continued growth across all the markets and improved productivity which is reflected in the healthy EBITDA margin and RoCE. Our research teams are working on several potential remedies for COVID in addition to the already launched products."

Shares of DR.REDDY'S LABORATORIES LTD. was last trading in BSE at Rs.5100.3 as compared to the previous close of Rs. 4980.15. The total number of shares traded during the day was 80994 in over 9023 trades.

The stock hit an intraday high of Rs. 5125.15 and intraday low of 4960.8. The net turnover during the day was Rs. 407655332.

Source : Equity Bulls

Keywords